138 related articles for article (PubMed ID: 32376222)
21. The Antibacterial Effects of Antimicrobial Peptides OP-145 against Clinically Isolated Multi-Resistant Strains.
Ming L; Huang JA
Jpn J Infect Dis; 2017 Nov; 70(6):601-603. PubMed ID: 28890511
[TBL] [Abstract][Full Text] [Related]
22. An antimicrobial bicyclic peptide from chemical space against multidrug resistant Gram-negative bacteria.
Di Bonaventura I; Baeriswyl S; Capecchi A; Gan BH; Jin X; Siriwardena TN; He R; Köhler T; Pompilio A; Di Bonaventura G; van Delden C; Javor S; Reymond JL
Chem Commun (Camb); 2018 May; 54(40):5130-5133. PubMed ID: 29717727
[TBL] [Abstract][Full Text] [Related]
23. Venom-derived peptide Mastoparan-1 eradicates planktonic and biofilm-embedded methicillin-resistant Staphylococcus aureus isolates.
Memariani H; Memariani M; Pourmand MR
Microb Pathog; 2018 Jun; 119():72-80. PubMed ID: 29626660
[TBL] [Abstract][Full Text] [Related]
24. Caerin 1.1 and 1.9 Peptides from Australian Tree Frog Inhibit Antibiotic-Resistant Bacteria Growth in a Murine Skin Infection Model.
Chen S; Zhang P; Xiao L; Liu Y; Wu K; Ni G; Li H; Wang T; Wu X; Chen G; Liu X
Microbiol Spectr; 2021 Sep; 9(1):e0005121. PubMed ID: 34259550
[TBL] [Abstract][Full Text] [Related]
25. A Novel Peptide-Based Antimicrobial Wound Treatment is Effective Against Biofilms of Multi-Drug Resistant Wound Pathogens.
Bayramov D; Li Z; Patel E; Izadjoo M; Kim H; Neff J
Mil Med; 2018 Mar; 183(suppl_1):481-486. PubMed ID: 29635548
[TBL] [Abstract][Full Text] [Related]
26. Anti-biofilm and anti-inflammatory effects of Lycosin-II isolated from spiders against multi-drug resistant bacteria.
Oh JH; Park J; Park Y
Biochim Biophys Acta Biomembr; 2022 Feb; 1864(1):183769. PubMed ID: 34506798
[TBL] [Abstract][Full Text] [Related]
27. Combined Efficacy of an Antimicrobial Cationic Peptide Polymer with Conventional Antibiotics to Combat Multidrug-Resistant Pathogens.
Thappeta KRV; Vikhe YS; Yong AMH; Chan-Park MB; Kline KA
ACS Infect Dis; 2020 May; 6(5):1228-1237. PubMed ID: 32138506
[TBL] [Abstract][Full Text] [Related]
28. Use of the antimicrobial peptide Epinecidin-1 to protect against MRSA infection in mice with skin injuries.
Huang HN; Rajanbabu V; Pan CY; Chan YL; Wu CJ; Chen JY
Biomaterials; 2013 Dec; 34(38):10319-27. PubMed ID: 24075409
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of ARV-1502, a Proline-Rich Antimicrobial Peptide, in a Murine Model of Bacteremia Caused by Multi-Drug Resistant (MDR)
Xiong YQ; Li L; Zhou Y; Kraus CN
Molecules; 2019 Aug; 24(15):. PubMed ID: 31382389
[No Abstract] [Full Text] [Related]
30. Haloganan: a novel antimicrobial peptide for treatmentof wound infections.
Shin SH; Kim B; Park S; Jo S; Lee IH
Peptides; 2014 Dec; 62():137-43. PubMed ID: 25445605
[TBL] [Abstract][Full Text] [Related]
31. An engineered arginine-rich α-helical antimicrobial peptide exhibits broad-spectrum bactericidal activity against pathogenic bacteria and reduces bacterial infections in mice.
Yang CH; Chen YC; Peng SY; Tsai AP; Lee TJ; Yen JH; Liou JW
Sci Rep; 2018 Oct; 8(1):14602. PubMed ID: 30279591
[TBL] [Abstract][Full Text] [Related]
32. Histone H5 is a potent Antimicrobial Agent and a template for novel Antimicrobial Peptides.
Jodoin J; Hincke MT
Sci Rep; 2018 Feb; 8(1):2411. PubMed ID: 29402952
[TBL] [Abstract][Full Text] [Related]
33. Anti-infective efficacy of the lactoferrin-derived antimicrobial peptide HLR1r.
Björn C; Mahlapuu M; Mattsby-Baltzer I; Håkansson J
Peptides; 2016 Jul; 81():21-8. PubMed ID: 27155369
[TBL] [Abstract][Full Text] [Related]
34. Catechol cross-linked antimicrobial peptide hydrogels prevent multidrug-resistant
Khan A; Xu M; Wang T; You C; Wang X; Ren H; Zhou H; Khan A; Han C; Li P
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31138760
[TBL] [Abstract][Full Text] [Related]
35. Preliminary investigations into developing all-D Omiganan for treating Mupirocin-resistant MRSA skin infections.
Ng SMS; Teo SW; Yong YE; Ng FM; Lau QY; Jureen R; Hill J; Chia CSB
Chem Biol Drug Des; 2017 Dec; 90(6):1155-1160. PubMed ID: 28581672
[TBL] [Abstract][Full Text] [Related]
36. A model for evaluating topical antimicrobial efficacy against methicillin-resistant Staphylococcus aureus biofilms in superficial murine wounds.
Roche ED; Renick PJ; Tetens SP; Carson DL
Antimicrob Agents Chemother; 2012 Aug; 56(8):4508-10. PubMed ID: 22644024
[TBL] [Abstract][Full Text] [Related]
37. In vitro bactericidal activity of levonadifloxacin (WCK 771) against methicillin- and quinolone-resistant Staphylococcus aureus biofilms.
Tellis M; Joseph J; Khande H; Bhagwat S; Patel M
J Med Microbiol; 2019 Aug; 68(8):1129-1136. PubMed ID: 31241446
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of methicillin resistant
Upreti N; Rayamajhee B; Sherchan SP; Choudhari MK; Banjara MR
Antimicrob Resist Infect Control; 2018; 7():121. PubMed ID: 30338059
[TBL] [Abstract][Full Text] [Related]
39. Polysaccharide-Peptide Cryogels for Multidrug-Resistant-Bacteria Infected Wound Healing and Hemostasis.
Hou S; Liu Y; Feng F; Zhou J; Feng X; Fan Y
Adv Healthc Mater; 2020 Feb; 9(3):e1901041. PubMed ID: 31867889
[TBL] [Abstract][Full Text] [Related]
40. In vivo efficacy of the antimicrobial peptide ranalexin in combination with the endopeptidase lysostaphin against wound and systemic meticillin-resistant Staphylococcus aureus (MRSA) infections.
Desbois AP; Gemmell CG; Coote PJ
Int J Antimicrob Agents; 2010 Jun; 35(6):559-65. PubMed ID: 20206480
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
